Coronary Heart Disease
Conditions
Interventions
Metabolic Syndrome Group:Null
Stable stable Coronary Heart Disease:Null
Acute Coronary Syndrome/Percutaneous Coronary Intervention/ Coronary Artery Bypass Graft Group:Null
Heart Failure Based on Coronary Heart Disease Group:Null
Sponsors
China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) the patient who aged from 35 to 85 years; (2) the patient who had signed the informed consent form and voluntarily participated in the study.
Exclusion criteria
Exclusion criteria: (1) patients with infection, fever, trauma, burns, surgical history, or active tuberculosis or rheumatic diseases in the past 1 weeks; (2) patients with heart valve disease (a valve and more than the occurrence of moderate lesions) or primary cardiomyopathy; (3) patients with acute exacerbation of chronic obstructive pulmonary disease or chronic pulmonary heart disease or respiratory failure; (4) patients with known renal insufficiency, serum creatinine (Cr) male > 221umol/L, female > 177 umol/L; (5) patients with known liver dysfunction, alanine aminotransferase (ALT) > 3 times the normal value of the patients with cirrhosis; (6) patients with severe primary diseases such as hematopoietic system or malignant tumor; (7) organ transplant patients; (8) patients with severe mental disorders (perceived barriers, mental disorders); (9) pregnant women and lactating women; (10) the researchers think that there are not suitable to participate in the study of other circumstances
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TCM Syndrome Evaluation Scale; | — |
Countries
China
Contacts
Public ContactHu Jingqing
Institution of Basic Theory of Traditional Chinese Medicine, China Academy of Chinese Medical Sciences
Outcome results
None listed